iSonea products recognised at CES
iSonea (ASX:ISN) has revealed that its asthma monitoring technology was selected to receive a digital technology award at the Consumer Electronics Show, held in Las Vegas in early January.
The company has been given a Tech Podcast Network Innovator Pick Award for its AirSonea wheeze monitoring device.
AirSonea launched in Australia in September last year. The product also has CE Mark approval in Europe, and iSonea is aiming for a US launch this year.
The award also recognises iSonea’s AsthmaSense Prime, the smartphone app used to keep tabs on asthma symptoms.
AsthmaSense Prime uses symptoms, triggers, environmental factors and medication usage statistics to inform patients about changing asthma risks.
iSonea last year added cloud capabilities to its AsthmaSense symptom monitoring system and received a Frost & Sullivan Innovation Award for its efforts.
iSonea (ASX:ISN) shares were trading 4.11% higher at $0.38 as of around 1 pm on Thursday.
Australia's first cases of H5 avian influenza confirmed
Positive results for H5 avian influenza (bird flu) have been confirmed in two seabirds found in...
AusBiotech partners with Tenmile
Designed to support Australia's homegrown life sciences innovation, AusBiotech has announced...
Australian CDC issues update in wake of Ebola outbreak
After the WHO determined the outbreak of Ebola in the DRC and Uganda to be a public health...
